Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Portal vein tumor thrombus"
Filter
Filter
Article category
Publication year
Case Reports
Living Donor Liver Transplantation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
YoungRok Choi, Kwang-Woong Lee, Hae Won Lee, Nam-Joon Yi, Kyung-Suk Suh
Journal of the Korean Liver Cancer Study Group. 2013;13(1):62-64.   Published online February 28, 2013
DOI: https://doi.org/10.17998/jlc.13.1.62
  • 1,445 Views
  • 9 Downloads
AbstractAbstract PDF
Malignant portal vein thrombosis is a contraindication to liver transplantation for hepatocellular carcinoma because of the high risk of its recurrence and the poor patient survival. With a newly developed immunosuppressant and a chemotherapeutic agent, however, living donor liver transplantation can be considered for a patient of hepatocellular carcinoma, showing a slow growth rate and good response for transarterial chemoembolization. We report a HBV related liver cirrhosis patient with HCC and portal vein tumor thrombus who underwent living donor liver transplantation and survived without recurrence of hepatocellular carcinoma for 18 months in our center.
Close layer
A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombi which was Performed Hepatectomy after Down-staging by Proton Therapy
Hee-Jung Wang, Bong-Wan Kim, Wei-Kwang Xu
Journal of the Korean Liver Cancer Study Group. 2011;11(1):56-59.   Published online February 28, 2011
  • 803 Views
  • 1 Download
AbstractAbstract PDF
A case of hepatocellular carcinoma (HCC) with portal vein tumor thrombi (PVTT) which was performed hepatectomy after down-staging by proton therapy is reviewed. Generally, the recommended therapeutic strategy for this kind of HCC is radiation therapy, systemic or infusion anticancer chemotherapy. However, the response of HCC and its PVTT of this 56 year-old male patient was relatively good after 22 times of proton therapy, and we performed right hemihepatectomy on the concept of clinical trial under the informed consent of patient and his families. He is still alive without recurrence 15 months after hepatectomy. We suggest that hemihepatectomy with removal of PVTT could be an alternative strategy in the PVTT accompanied HCC cases who show good responses after the above generally recommended therapies.
Close layer
A Case of Hepatocelluar Carcinoma with Portal Vein Tumor Thrombus arterial
Jong Kyu Park, Young Seok Kim, Sang Gyune Kim, Seung Won Jeong, Jae Young Jang, Hyun Jong Choi, Jong Ho Moon, Hong Soo Kim, Moon Sung Lee, Chan Sup Shim, Boo Sung Kim
Journal of the Korean Liver Cancer Study Group. 2009;9(1):49-52.   Published online June 30, 2009
  • 619 Views
  • 0 Download
AbstractAbstract PDF
Recent progress in imaging techniques has permitted the diagnosis of hepatocelluar carcinoma (HCC) at an early stage. However, portal vein invasion is still found in 12.5~39.7%. HCC with tumor thrombosis of the portal vein has a poor prognosis. Previous studies showed that the median survival time of patients with HCC with involving portal vein was 2.7~4 months if effective treatment was not administered. Thus, for such HCC with portal vain invasion, an effective therapy that will maintain quality of life is required. We report a case of HCC with portal vein tumor thrombus treated by intra-arterial chemotherapy.
Close layer

JLC : Journal of Liver Cancer
TOP